Eastman Ronald W
Insider CIK 1597585 · PSDV Director · RVNC Director, 10% owner · CORI Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-29 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-29 | 20,000 | $12.50 | $250.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-29 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | U Tender | 2018-11-27 | 2018-11-29 | 9,353,304 | $12.50 | $116.92M | 0 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2017-12-01 | 2017-12-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-05-11 | 2017-05-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-05-11 | 2017-05-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CORI Corium International, Inc. | C Conversion deriv | 2014-04-08 | 2014-04-08 | 6,859,066 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | C Conversion deriv | 2014-04-08 | 2014-04-08 | 20,485,926 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | C Conversion deriv | 2014-04-08 | 2014-04-08 | 1,999,898 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 397,718 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 26,385 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 214,149 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 1,114 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 218,279 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 109,015 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | C Conversion deriv | 2014-04-08 | 2014-04-08 | 3,387,146 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | X Exercise deriv | 2014-04-08 | 2014-04-08 | 54,507 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-04-08 | 2014-04-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 218,279 | — | $0 | 3,565,069 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 1,114 | — | $0 | 3,346,790 | SEC↗ |
| CORI Corium International, Inc. | C Conversion | 2014-04-08 | 2014-04-08 | 1,999,898 | — | $0 | 8,953,304 | SEC↗ |
| CORI Corium International, Inc. | C Conversion | 2014-04-08 | 2014-04-08 | 3,387,146 | — | $0 | 6,953,406 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 397 | — | $0 | 3,566,260 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 794 | — | $0 | 3,565,863 | SEC↗ |
| CORI Corium International, Inc. | C Conversion | 2014-04-08 | 2014-04-08 | 679,115 | — | $0 | 679,115 | SEC↗ |
| CORI Corium International, Inc. | C Conversion | 2014-04-08 | 2014-04-08 | 2,028,309 | — | $0 | 2,707,424 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 397,718 | — | $0 | 3,105,142 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 26,385 | — | $0 | 3,131,527 | SEC↗ |
| CORI Corium International, Inc. | X Exercise | 2014-04-08 | 2014-04-08 | 214,149 | — | $0 | 3,345,676 | SEC↗ |
| CORI Corium International, Inc. | P Buy | 2014-04-08 | 2014-04-08 | 400,000 | $8.00 | $3.20M | 9,353,304 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 56,485 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 18,037 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 26,605 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 43,029 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 29,137 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 129,916 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 41,485 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 369,124 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 596,812 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 404,124 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 1,801,888 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 575,384 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 11,560 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 12,668 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 18,708 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 18,708 | — | $0 | 105,898 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 596,812 | — | $0 | 3,378,208 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 2,781,396 | — | $0 | 2,781,396 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 11,560 | — | $0 | 117,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 369,124 | — | $0 | 3,747,332 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 87,190 | — | $0 | 87,190 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 26,605 | — | $0 | 270,172 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 43,029 | — | $0 | 243,567 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 200,538 | — | $0 | 200,538 | SEC↗ |